Travel medicine & Infectiology & Internal medicine
Traveler's diarrhea
Traveler's diarrhea (TD) - commonly known as «turista» or «Montezuma's revenge» - is defined as the occurrence of at least 3 loose or watery stools per 24 hours in travelers to high-risk destinations, often accompanied by abdominal cramps, nausea, vomiting and general malaise. It is the most common infectious disease among international travellers: 20 to 50 % of travellers from North America to tropical and subtropical regions of Africa, Asia and Latin America are affected - representing 10 to 12 million Canadians every year. Contamination is almost exclusively food- and water-borne (faecal-oral route) - the golden rule of prevention remains «cook it, peel it, boil it or forget it». In 80 to 90 % of cases, the causative agents are enteropathogenic bacteria, of which enterotoxigenic Escherichia coli (ETEC) accounts for 30 to 50 % of cases, and is the main target of empirical antibiotic treatment. Most episodes are benign and self-limiting within 1 to 5 days, but dehydration, febrile forms with dysentery (glairo-bloody stools) and resistant parasitic etiologies (Giardia, Cryptosporidium) may require medical evaluation abroad or on return. Canadian travellers returning from endemic areas should consult a physician in the event of symptoms lasting more than 14 days, fever, blood in the stools or signs of dehydration.
Causal agents
| Pathogen | Frequency | Clinical and epidemiological characteristics |
|---|---|---|
| ETEC - E. coli enterotoxinogen | 30-50 % | Main agent of traveler's diarrhea - produces thermostable (ST) and thermolabile (LT) enterotoxins stimulating chlorine and water secretion in the intestinal lumen (secretory mechanism) → profuse watery diarrhea, abdominal cramps, nausea ; abrupt onset 6-72h after ingestion; duration 3-5 days; no fever or blood in stools - spontaneously favorable evolution; priority target for empirical antibiotic treatments (rifaximin, azithromycin) |
| Other E. coli pathogens EAEC, EPEC, EIEC, EHEC |
10-20 % | EAEC (E. coli enteroaggregative): 2nd cause of bacterial DV - persistent diarrhoea (>14 days) - often associated with immunocompromised travellers; EIEC (E. coli enteroinvasive): dysenteric picture (bloody stools, fever); EHEC O157:H7: rare when travelling - hemolytic uremic syndrome possible - contraindication to antibiotics |
| Campylobacter jejuni | 5-15 % | Undercooked poultry, contaminated water - Southeast Asia (Thailand, India) in particular; febrile diarrhea with intense abdominal cramps, blood in stool possible; high fluoroquinolone resistance in Southeast Asia (>80 % in Thailand) → azithromycin as first-line treatment in these regions; rare complication: Guillain-Barré syndrome (post-infectious autoimmune sequela) |
| Salmonella non-typhoidal | 3-7 % | Undercooked eggs and poultry, unpasteurized dairy products; fever, sometimes bloody diarrhea, bacteremia possible in the immunocompromised and sickle cell patients (risk of Salmonella osteomyelitis); antibiotics not routinely recommended in mild forms as they prolong healthy carriage; treatment if high fever or immunocompromised: fluoroquinolones or azithromycin. |
| Shigella spp. | 3-7 % | Main bacterial cause of dysentery (bloody stools + high fever + tenesmus) - very low infecting dose (10-100 bacteria sufficient); South Asia, sub-Saharan Africa; frequent resistance to fluoroquinolones - azithromycin first choice; complication: hemolytic uremic syndrome (S. dysenteriae type 1 - rare on trips) |
| Giardia intestinalis | 3-10 % | Protozoan - main cause of chronic traveler's diarrhea (>14 days) and post-return diarrhea; contamination by untreated water (trekking, camping) or food - long incubation period: 1-3 weeks; intermittent watery diarrhea, pale greasy stools (steatorrhea), bloating, malodorous flatulence, weight loss; diagnosis: coproparasitology (low sensitivity - 3 coprocultures) or Giardia fecal antigen (ELISA - sensitivity 95 %) or PCR; treatment: metronidazole 250 mg 3×/day × 5-7 days or tinidazole 2 g single dose (better compliance) |
| Cryptosporidium spp. | 2-5 % | Intracellular protozoa - resistant to water chlorination - highly resistant oocysts in the environment; profuse watery diarrhea often self-limited (1-2 weeks) in immunocompetent but potentially severe and chronic in the immunocompromised (HIV CD4 <100 - choleriform diarrhea - Cryptosporidium colangiopathy); diagnosis: fecal antigen or PCR (classical coproparasitology not very sensitive); treatment: nitazoxanide 500 mg 2×/day × 3 days (immunocompetent) - no effective treatment in the profoundly immunocompromised without immune restoration |
| Cyclospora cayetanensis | 1-3 % | Nepal, Peru, Guatemala, Mexico - contamination by raspberries, fresh basil, water - documented food epidemics in North America; cyclic prolonged watery diarrhea (alternating diarrhea/constipation), intense fatigue, anorexia, weight loss - lasts up to 6 weeks without treatment; diagnosis: parasitological stool examination with special staining (UV autofluorescence - oocysts 8-10 µm); treatment: trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg 2×/day × 7-10 days |
| Viruses (norovirus, rotavirus) | 5-10 % | Norovirus: main cause of gastroenteritis on cruise ships - highly contagious - direct transmission person-to-person + food + surfaces; brutal onset, vomiting predominant, lasts 24-72h, spontaneous resolution; rotavirus: especially children - vaccine available (Rotarix, RotaTeq); no specific antiviral treatment - symptomatic treatment + oral rehydration. |
Clinical classification and treatment according to severity
- Mild DV (1-2 bowel movements/day, no incapacity): sufficient oral rehydration (ORS or salted beverages + foods rich in salt); loperamide (Imodium) 4 mg then 2 mg after each liquid bowel movement - maximum 16 mg/24h - accelerates resolution of symptoms and allows travel, taking a plane, attending a meeting; loperamide contraindicated if fever >38.5°C or blood in stools (risk of toxic megacolon in invasive dysentery).
- Moderate DV (3-6 stools/day with disability or mild systemic signs): self-medication with pre-prescribed travel kit - azithromycin 1 g single dose or 500 mg/day × 3 days (Southeast Asia, India, Africa - covers fluoroquinolone-resistant Campylobacter and Shigella); rifaximin 200 mg 3×/day × 3 days (Mexico, Latin America, regions with predominant ETEC - not absorbed, no systemic effects); loperamide in combination with antibiotic (reduces duration of symptoms)
- Severe DV (≥7 stools/day, high fever, blood in stools, dehydration, total incapacity): on-site medical consultation imperative; azithromycin 500 mg/day × 3 days or single dose 1 g (fluoroquinolones avoided in Southeast Asia - high Campylobacter resistance); hospitalization if signs of sepsis, severe dehydration or no response to outpatient treatment; coprocultures and parasitology before or after empirical treatment.
- Persistent diarrhea on return (>14 days): travel medicine or infectiology consultation; complete parasitological work-up (3 stools 48 hours apart with Giardia and Cryptosporidium antigens + PCR parasites depending on center); exclude Giardia, Cyclospora, Entamoeba histolytica (amoebiasis - hematophagous trophozoites in stools), Isospora belli, Strongyloïdes stercoralis (possible hyperinfection in immunocompromised patients); consider colonoscopy if parasitological workup negative and diarrhea persistent (>4 weeks) - exclude chronic inflammatory disease (IBD) triggered or revealed by the infectious episode (post-infectious irritable bowel syndrome : 10-15 % of bacterial DV)
Empirical antibiotic treatment - choice according to destination
| Travel region | 1st-line antibiotic | Rationale and dosage |
|---|---|---|
| Southeast Asia (Thailand, India, Nepal, Vietnam, Philippines, Cambodia, Laos) | Azithromycin | Very high fluoroquinolone resistance to Campylobacter (>80 % in Thailand) and Shigella in this region → fluoroquinolones (ciprofloxacin) ineffective; dosage: 1 g single dose or 500 mg/day × 3 days; ETEC + Campylobacter + Shigella coverage; safe in pregnancy (safer alternative to ciprofloxacin) |
| Mexico, Central America, Caribbean, South America | Rifaximin or azithromycin | Rifaximin 200 mg 3×/day × 3 days - not absorbed, acts locally in the intestinal lumen - very well tolerated - rare resistance - ideal for non-febrile, non-bloody diarrhea (ETEC predominant); if fever or blood in stool → azithromycin (rifaximin ineffective on invasive agents because no absorption); ciprofloxacin acceptable if low local resistance (Mexico <15-20 % of ETEC resistance to FQ). |
| Sub-Saharan Africa, Middle East, Maghreb | Azithromycin | Increasing resistance to fluoroquinolones (Shigella, ETEC) in sub-Saharan Africa and the Middle East → azithromycin preferred; ciprofloxacin still acceptable in some parts of the Maghreb (resistance <30 %); always azithromycin if fever or dysentery |
| Eastern Europe, Southern Europe, Turkey | Azithromycin or ciprofloxacin | Risk lower than in tropical areas - fluoroquinolone resistance variable; ciprofloxacin 500 mg 2×/day × 3 days still often effective in Southern Europe and Turkey; azithromycin if Campylobacter suspected (undercooked poultry) |
| Suspected persistent or parasitic DV | Metronidazole or tinidazole (Giardia); TMP-SMX (Cyclospora); nitazoxanide (Cryptosporidium) | Giardia: metronidazole 250 mg 3×/day × 7 days or tinidazole 2 g single dose (better compliance); Cyclospora: TMP-SMX 160/800 mg 2×/day × 7-10 days; Cryptosporidium immunocompetent: nitazoxanide 500 mg 2×/day × 3 days; Entamoeba histolytica (invasive intestinal amebiasis): metronidazole 500-750 mg 3×/day × 10 days + paromomycin to eliminate luminal cysts. |
Prevention
- Food and water precautions - basic rules: consume only bottled water (check that the seal is intact), boiled water (boil for 1 min - sufficient to kill all pathogens, including Cryptosporidium) or treated water (travel filter + chlorine or iodine tablets - tablets alone are insufficient against Cryptosporidium) ; ice to be avoided if source water uncertain; raw fruit and vegetables to be peeled yourself (do not eat green salad, cut tomatoes, unpeeled fruit in local restaurants); well-cooked meat and fish; avoid street food and room-temperature buffets (rapid bacterial proliferation at tropical temperatures)
- Hand hygiene: wash thoroughly with soap before meals and after using the toilet - use hydro-alcoholic gel as a back-up (does not replace washing with soap against Cryptosporidium and Cyclospora oocysts, which are resistant to alcohol).
- Hemoprophylaxis: not systematically recommended by Health Canada (selection of resistances, adverse effects) - may be considered in special circumstances: immunocompromised travelers (HIV, transplant patients, chemotherapy), short trip with critical stakes (official delegation, sports competition, honeymoon), history of recurrent severe traveler's diarrhea; rifaximin 200 mg/day prophylaxis: 70-80 % risk reduction (studies in Mexico) - ETEC coverage only; bismuth subsalicylate (Pepto-Bismol) 2 tablets 4×/day: 40-65 % risk reduction - side effects: blackening of stools and tongue, tinnitus at high doses; Saccharomyces boulardii (probiotic): modest reduction (20-30 %) - good tolerance - complementary option
- Preventive vaccines: oral cholera vaccine (Dukoral) - cross-protection against ETEC-LT from 50-67 % (2 doses per os spaced 1-6 weeks apart, last dose ≥1 week before departure) - indicated for high-risk travelers or patients with underlying intestinal disease (IBD) - not reimbursed by RAMQ but covered by some travel insurances; rotavirus vaccine (Rotarix, RotaTeq) - recommended for infants from 6 weeks of age according to the Quebec vaccination schedule (indirect protection for traveling infants)
- Travel kit to be prepared with doctor prior to departure: ORS (Gastrolyte sachets); loperamide 2 mg (Imodium); azithromycin 500 mg (medical prescription required) ± rifaximin 200 mg depending on destination; antimalarial if endemic destination; written instructions on self-medication regimen depending on severity.
ℹ️
Visit post-infectious irritable bowel syndrome (IBS-PI) occurs in 10-15 % of travellers with bacterial traveller's diarrhoea - especially after infection with Campylobacter, Salmonella or Shigella. Symptoms persist months to years after resolution of the acute infection: alternating diarrhea/constipation, abdominal pain, bloating. Patients presenting with chronic digestive symptoms after travel should benefit from a full parasitological work-up before attributing the symptoms to IBS-IP - in particular to exclude an infestation with Giardia, Cyclospora or Entamoeba histolytica.
Signs requiring urgent medical attention
Consult a physician on site or in the emergency room if, during your trip, you experience: blood in the stools (dysentery); fever >38.5°C associated with diarrhea (invasive infection - Shigella, Salmonella, Campylobacter); signs of severe dehydration (absence of urine for >8h, dizziness on rising, confusion, very dry mouth, sunken eyes) ; incoercible vomiting preventing oral rehydration; profuse diarrhea (>10 liquid stools/24h); intense, localized abdominal pain (possible peritonitis if perforation); diarrhea persisting for more than 7 days without improvement under empirical antibiotic treatment.
Upon return to Québec: consult a physician if diarrhea persists for more than 14 days after return, Some parasitoses (amoebiasis, strongyloidiasis) can take a long time to appear.
Consult at Clinique Omicron
Clinique Omicron physicians offer pre-travel medicine consultations (risk assessment, prescription of self-medication kit, travel vaccines including Dukoral, personalized prevention advice depending on destination) and return consultations for persistent or febrile post-travel diarrhea (coprocultures, parasitology, fecal antigens, PCR, referral if necessary). Consultations are available at our points of service in Quebec, as well as via telemedicine. To book an appointment, visit cliniqueomicron.ca.
The contents of this page are provided for information purposes only and do not replace the advice of a qualified health professional. Any traveler who develops fever, blood in the stool or persistent diarrhea after a trip to a tropical zone should consult a physician promptly.
Omicron Clinic
Need to consult a doctor?
Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.
Insurance receipts. 7j/7. No family doctor required.